Sinovac Biotech Ltd's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 1.35, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Sinovac Biotech Ltd in Dec 31 2025 quarter, has decreased to 270 days, compared to 294 days, in the 0 quarter.

If we take a look into Healthcare sector 563 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 3896.

What is Receivable Turnover Ratio?
What is Sinovac Biotech Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SVA Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-6.6 %	-6.6 %	-6.6 %	-6.6 %	-27.86 %
Y / Y Revenue Change	7.01 %	-	-	-	-19.45 %
Receivable Turnover Ratio (TTM)	1.35	1.24	1.22	1.2	1.18
SVA's Total Ranking	# 3896	# 0	#	#	#
Accounts Receivable average collection period days	271	295	300	305	310
Seq. Receivable Change	0 %	0 %	0 %	-6.6 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 197
Healthcare Sector	# 564
Overall Market	# 3896

Receivable Turnover Ratio Statistics
High	Average	Low
1.16	0.37	0.03
(Dec 31 2021)		(Dec 31 2024)

SVA Company Profile • Back to SVA Efficiency Comparisons • Compare SVA Receivables Turnover Ratio to its Competitors

Financial Statements
Sinovac Biotech Ltd's Accounts Receivable	$ 286 Millions	Visit SVA's Balance sheet
Sinovac Biotech Ltd's Sales TTM	$ 386 Millions	Visit SVA's Income Statement
Sources of SVA's Revenues		Visit SVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SVA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SVA's Growth Rates	SVA's Roa	SVA's Inventory Turnover Ratio	SVA's Dividend Comparisons
SVA's Profitability Ratios	SVA's Roi	SVA's Asset Turnover Ratio	SVA's Dividend Growth
SVA's Valuation Ratios	SVA's Roe	SVA's Financial Strength Ratios	SVA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Lightwave Logic Inc	3.70	$ 0.237 Millions	$ 0.064 Millions
Organogenesis Holdings Inc	3.70	$ 564.169 Millions	$ 152.484 Millions
Cumberland Pharmaceuticals Inc	3.70	$ 44.521 Millions	$ 12.045 Millions
Apollomics Inc	3.69	$ 8.500 Millions	$ 2.305 Millions
Align Technology inc	3.68	$ 4,034.013 Millions	$ 1,094.829 Millions
Xencor Inc	3.68	$ 125.576 Millions	$ 34.111 Millions
Eli Lilly And Company	3.68	$ 65,179.000 Millions	$ 17,705.250 Millions
Inspiremd Inc	3.67	$ 8.649 Millions	$ 2.359 Millions
Lexicon Pharmaceuticals Inc	3.67	$ 49.803 Millions	$ 13.587 Millions
Sanofi	3.66	$ 52,321.040 Millions	$ 14,306.880 Millions
Absci Corp	3.63	$ 2.800 Millions	$ 0.771 Millions
Ani Pharmaceuticals Inc	3.61	$ 883.366 Millions	$ 244.922 Millions
Esperion Therapeutics Inc	3.60	$ 403.135 Millions	$ 112.053 Millions
Outset Medical Inc	3.57	$ 118.754 Millions	$ 33.268 Millions
Hutchmed china Limited	3.54	$ 548.512 Millions	$ 155.127 Millions
Medinotec Inc	3.53	$ 10.325 Millions	$ 2.922 Millions
Collegium Pharmaceutical Inc	3.51	$ 779.328 Millions	$ 221.753 Millions
Evofem Biosciences Inc	3.51	$ 20.183 Millions	$ 5.750 Millions
Ars Pharmaceuticals Inc	3.50	$ 84.278 Millions	$ 24.057 Millions
Cytek Biosciences Inc	3.48	$ 200.451 Millions	$ 57.601 Millions
Apellis Pharmaceuticals Inc	3.46	$ 1,003.782 Millions	$ 290.284 Millions
Tonix Pharmaceuticals Holding Corp	3.41	$ 13.107 Millions	$ 3.846 Millions
Tenon Medical Inc	3.38	$ 3.944 Millions	$ 1.166 Millions
Alvotech	3.32	$ 588.904 Millions	$ 177.506 Millions
Arcutis Biotherapeutics Inc	3.32	$ 376.072 Millions	$ 113.362 Millions
Krystal Biotech Inc	3.30	$ 389.130 Millions	$ 117.939 Millions
Axsome Therapeutics Inc	3.27	$ 638.496 Millions	$ 195.299 Millions
Novo Nordisk A	3.25	$ 309,064.000 Millions	$ 95,092.083 Millions
Astrotech Corp	3.22	$ 1.199 Millions	$ 0.372 Millions
Phathom Pharmaceuticals Inc	3.16	$ 175.110 Millions	$ 55.384 Millions

Date modified: 2026-07-07T13:28:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.